TGRX-326 Pharmacokinetic Food Effect Bioavailability Study

Clinical trial NCT06304805 · COMPLETED

Trial details

NCT number: NCT06304805
Sponsor: Shenzhen TargetRx Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer

Start date: 2023-12-13
Primary completion: 2024-01-12
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.